On November 20, 2023, Plus Therapeutics Inc (NASDAQ: PSTV) opened at $2.22, lower -27.76% from the last session. During the day, the shares moved up to $2.50 and dropped to $1.66 before settling in for the closing price of $2.63. Price fluctuations for PSTV have ranged from $0.97 to $7.35 over the past 52 weeks.
Annual sales at Healthcare sector company slipped by -10.03% over the past five years. Company’s average yearly earnings per share was noted 58.10% at the time writing. With a float of $4.42 million, this company’s outstanding shares have now reached $4.52 million.
Let’s look at the performance matrix of the company that is accounted for 17 employees. In terms of profitability, gross margin is -217.86, operating margin of -8800.00, and the pretax margin is -9051.34.
Plus Therapeutics Inc (PSTV) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Plus Therapeutics Inc is 2.23%, while institutional ownership is 1.95%. The most recent insider transaction that took place on Nov 16, was worth 1,950. In this transaction Director of this company bought 1,000 shares at a rate of $1.95, taking the stock ownership to the 25,160 shares. Before that another transaction happened on Nov 15, when Company’s Director bought 1,000 for $1.77, making the entire transaction worth $1,770. This insider now owns 24,160 shares in total.
Plus Therapeutics Inc (PSTV) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 9/29/2023, the company posted -$1 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$1.12) by $0.12. This company achieved a net margin of -9051.34 while generating a return on equity of -234.65. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.4 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 58.10% per share during the next fiscal year.
Plus Therapeutics Inc (NASDAQ: PSTV) Trading Performance Indicators
Check out the current performance indicators for Plus Therapeutics Inc (PSTV). In the past quarter, the stock posted a quick ratio of 1.10. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.29.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.19, a number that is poised to hit -1.17 in the next quarter and is forecasted to reach -2.37 in one year’s time.
Technical Analysis of Plus Therapeutics Inc (PSTV)
Plus Therapeutics Inc (NASDAQ: PSTV) saw its 5-day average volume 0.35 million, a positive change from its year-to-date volume of 0.22 million. As of the previous 9 days, the stock’s Stochastic %D was 73.71%. Additionally, its Average True Range was 0.27.
During the past 100 days, Plus Therapeutics Inc’s (PSTV) raw stochastic average was set at 41.53%, which indicates a significant decrease from 43.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 203.26% in the past 14 days, which was higher than the 169.16% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.36, while its 200-day Moving Average is $3.05. Nevertheless, the first resistance level for the watch stands at $2.38 in the near term. At $2.86, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.22. If the price goes on to break the first support level at $1.54, it is likely to go to the next support level at $1.18. Assuming the price breaks the second support level, the third support level stands at $0.70.
Plus Therapeutics Inc (NASDAQ: PSTV) Key Stats
There are currently 4,523K shares outstanding in the company with a market cap of 8.59 million. Presently, the company’s annual sales total 220 K according to its annual income of -20,280 K. Last quarter, the company’s sales amounted to 1,240 K and its income totaled -3,220 K.